Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations | Zendy

Alison H. Thomson | Zendy; Christine E. Staatz | Zendy; C. M. Tobin | Zendy; M.A. Gall | Zendy; Andrew Lovering | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations

Author(s) -

Alison H. Thomson,

Christine E. Staatz,

C. M. Tobin,

M.A. Gall,

Andrew Lovering

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp085

Subject(s) - vancomycin , nonmem , trough concentration , pharmacokinetics , therapeutic drug monitoring , medicine , population , antibacterial agent , pharmacology , antibiotics , microbiology and biotechnology , biology , staphylococcus aureus , environmental health , bacteria , genetics

The aims of this study were to develop a population pharmacokinetic model of vancomycin in adult patients, to use this model to develop dosage guidelines targeting vancomycin trough concentrations of 10-15 mg/L and to evaluate the performance of these new guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research